Immatics N.V. Ordinary Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for IMTX, updated each market day.
IMTX AI Sentiment
AI predicts Immatics N.V. Ordinary Shares stock is likely to increase over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Immatics N.V. Ordinary Shares
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
Exchange
Market Cap
$1,495,176,822
Cap Tier
Employees
407
Listed Since
July 2, 2020
Website
IMTX Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
IMTX Volatility
Immatics N.V. Ordinary Shares has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.